Publications by authors named "Marta Amata"
Article Synopsis
- Increased rates of pneumomediastinum were noted in COVID-19 pneumonia patients, prompting a study to identify risk factors and understand their impact on clinical outcomes.
- The study compared 139 patients with pneumomediastinum to 153 similar patients who did not develop this condition, analyzing clinical and laboratory data to find correlations.
- Key findings indicated that factors like severe lung damage, low BMI, high inflammatory markers, and smoking history are linked to higher pneumomediastinum risk, which in turn leads to longer hospital stays, higher intubation rates, and increased mortality.
COVID-19 modified the healthcare system. Nasal-pharyngeal swab (NPS), with real-time reverse transcriptase-polymerase (PCR), is the gold standard for the diagnosis; however, there are difficulties related to the procedure that may postpone it. The study aims to evaluate whether other elements than the PCR-NPS are reliable and confirm the diagnosis of COVID-19.
View Article and Find Full Text PDFIntroduction: One of the most important complications of OSAHS in children is growth delay. The aim of this study was to investigate changes in clinical body growth, and laboratory growth in children with OSAHS after adeno-tonsillar surgery.
Materials And Methods: In our study, among 102 children suffering from sleep-disordered breathing, 70 met the inclusion criteria because they were affected by OSAHS and adenotonsillar hypertrophy.
Background: COVID-19 is an infectious disease caused by a Coronavirus in humans, namely SARS-CoV-2, which has quickly become a global pandemic. The infection is responsible for a severe form of pneumonia, which may lead to lung failure and death. Among the therapeutic strategies, the antiviral agent remdesivir has become one of the most used drugs.
View Article and Find Full Text PDFChronic rhinosinusitis (CRS) is a significant health problem. It affects 5-12% of the general population. The causes that underlie the onset of CRS are not yet well known.
View Article and Find Full Text PDFArticle Synopsis
- - This study investigated changes in smell and taste among asymptomatic and symptomatic COVID-19 patients in Sicily, noting variations in incidence between northern and southern Italy.
- - Out of 292 patients, 50 tested positive for SARS-CoV-2, with 52% of them reporting smell and taste disorders; the hospitalized group had more severe symptoms compared to the non-hospitalized group.
- - The findings suggest that most SARS-CoV-2 positive patients in southern Italy had milder symptoms and did not require hospitalization, although alterations in smell and taste were common.